PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34944620-15	2021	In cancer samples, NAADP reduced the activity of Na+/K+ ATPase by 9-times (p < 0.01) and the activity of Ca2+ ATPase EPR about 2-times (p < 0.05).	NAADP	19-24	carbonic anhydrase 2	Homo sapiens	105-116	
34944620-16	2021	NAADP caused a tendency to decrease the activity of Ca2+ ATPase of PM, but increased basal ATPase activity by 2-fold vs. the mean of this index in cancer samples without the addition of NAADP.	NAADP	0-5	carbonic anhydrase 2	Homo sapiens	52-63	
34944620-17	2021	In control samples NAADP caused only a tendency to decrease the activities of Na+/K+ ATPase and Ca2+ ATPase EPR, but statistically decreased the activity of Ca2+ ATPase of PM (p < 0.05).	NAADP	19-24	carbonic anhydrase 2	Homo sapiens	96-107	
34944620-17	2021	In control samples NAADP caused only a tendency to decrease the activities of Na+/K+ ATPase and Ca2+ ATPase EPR, but statistically decreased the activity of Ca2+ ATPase of PM (p < 0.05).	NAADP	19-24	carbonic anhydrase 2	Homo sapiens	157-168	
34944620-20	2021	NAADP caused a decrease in the activities of Na+/K+ ATPase and Ca2+ ATPase EPR in cancer samples and increased basal ATPase activity.	NAADP	0-5	carbonic anhydrase 2	Homo sapiens	63-74	
34944620-21	2021	In control samples, NAADP decreased Ca2+ ATPase of PM and increased basal ATPase activity.	NAADP	20-25	carbonic anhydrase 2	Homo sapiens	36-47